Argos Therapeutics

Argos Therapeutics, Inc. is an immunotherapy company developing new treatments for cancer, infectious and autoimmune diseases and transplantation rejection. The company has generated multiple platform technologies and a diverse pipeline of products based on its expertise in the biology of dendritic cells - the master switch that turns the immune system on or off.

Company Growth (employees)
Type
Public
HQ
Durham, US
Founded
1997
Size (employees)
136 (est)
Argos Therapeutics was founded in 1997 and is headquartered in Durham, US

Argos Therapeutics Office Locations

Argos Therapeutics has office in Durham
Durham, US

Argos Therapeutics Metrics

Argos Therapeutics Summary

Market capitalization

$37.3 m

Closing share price

$0.9
Argos Therapeutics's current market capitalization is $37.3 m.

Argos Therapeutics Financials

Argos Therapeutics's revenue is $2 m in FY, 2014 which is a 280.8% increase from the previous period.
FY, 2014FY, 2015

Revenue

$2 m$518.3 k

Revenue growth, %

(73.7%)

Operating expense total

$54.1 m$73.1 m

EBIT

($52.1 m)($72.5 m)

Net Income

($53.3 m)($74.8 m)

Operating cash flow

$3.9 m($31.1 m)

Argos Therapeutics Market Value History

Argos Therapeutics Online Presence

Argos Therapeutics Company Life

You may also be interested in